Anzeige
Mehr »
Freitag, 20.02.2026 - Börsentäglich über 12.000 News
Die größte Bewertungslücke im globalen Mental-Health-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
238 Leser
Artikel bewerten:
(1)

Bio Decontamination Market to Reach $525.4 million by 2033 Globally, at 8.7% CAGR: Allied Market Research

Rise in the prevalence of infectious diseases, increasing regulatory emphasis on contamination control, and rapid advancements in automated sterilization technologies are the major factors driving the growth of the global bio decontamination market.

WILMINGTON, Del., Feb. 19, 2026 /PRNewswire/ -- Allied Market Research published a report, titled, "Bio Decontamination Market by Product (Equipment and Consumables), Agent (Hydrogen Peroxide, Chlorine Dioxide and Nitrogen Dioxide), Type (Chamber Decontamination and Room Decontamination), and End User (Pharmaceutical and Biotechnology Companies and Healthcare Facilities): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the bio decontamination market was valued at $229.5 million in 2023, and is estimated to reach $525.4 million by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Allied Market Research Logo

Request Sample of the Report on Global Bio Decontamination Market 2033 - https://www.alliedmarketresearch.com/request-sample/A323971

Prime Determinants of Growth

The increasing incidence of hospital-acquired infections (HAIs), rising regulatory emphasis on contamination control, and rapid expansion of pharmaceutical and biotechnology manufacturing are the major factors driving the growth of the bio decontamination market. Growing awareness regarding biosafety standards and cleanroom validation further supports adoption across healthcare and research facilities. However, the high cost of advanced automated decontamination systems and complex regulatory approval processes may restrain market growth. Meanwhile, technological innovations in hydrogen peroxide vapor systems, IoT-enabled monitoring, and eco-friendly sterilization solutions offer significant opportunities for the expansion of the global bio decontamination market.

Report Coverage & Details

Report Coverage

Details

Forecast Period

2024-2033

Base Year

2023

Market Size in 2023

$229.5 million

Market Size in 2033

$525.4 million

CAGR

8.7 %

No. of Pages in Report

280

Segments Covered

Product, Agent, Type, End User, and Region

Drivers

• Increasing awareness about the importance of maintaining sterile environments

• Growing biopharmaceutical industry.

• Rise in hospital-acquired infections (HAIs)

Opportunity

• Technological advancement in bio decontamination

Restraint

• High product cost

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A323971

In healthcare facilities, pharmaceutical production units, and research laboratories, bio decontamination technologies are used to eliminate harmful microorganisms such as bacteria, viruses, fungi, and spores from controlled environments. Advanced systems, including hydrogen peroxide vapor generators, chlorine dioxide gas systems, and nitrogen dioxide sterilization platforms, help maintain sterile cleanrooms, isolators, and critical patient care areas. These technologies support infection prevention strategies, ensure regulatory compliance with Good Manufacturing Practices (GMP), and enhance overall biosafety standards.

The bio decontamination market extends beyond routine sterilization into high-containment and emergency response applications. Innovations in automated cycle validation, IoT-enabled monitoring, and eco-friendly sterilants improve operational efficiency and minimize downtime. These advancements enhance reliability, reduce human intervention, and strengthen contamination control across healthcare and life sciences industries globally.

Segment Highlights

The equipment segment dominated the market share in 2023

By product, the equipment segment dominated the market share in 2023. This is attributed to the high adoption of automated bio decontamination systems, including vaporized hydrogen peroxide generators, integrated room decontamination units, and chamber-based sterilization systems. Pharmaceutical and biotechnology companies increasingly invest in advanced equipment to meet stringent regulatory standards and ensure validated sterilization cycles. Although consumables such as sterilant cartridges and chemical indicators generate recurring revenue, the higher capital value of equipment significantly contributes to segment dominance. Continuous innovation in automation and digital monitoring further strengthens growth.

The hydrogen peroxide segment accounted for the largest market share in 2023

By agent, hydrogen peroxide dominated the market in 2023 due to its strong antimicrobial efficacy, material compatibility, and environmentally safe residue profile. Hydrogen peroxide vapor (HPV) systems are widely used in cleanrooms, isolators, and hospital settings. Chlorine dioxide and nitrogen dioxide are also gaining traction, particularly in specialized applications requiring deep penetration and low-temperature sterilization.

Room decontamination led by type in 2023

By type, the room decontamination segment held the largest market share in 2023. Growing emphasis on hospital infection control and large-scale facility sterilization drives demand for full-room automated systems. Chamber decontamination remains essential in pharmaceutical manufacturing for isolators, pass-through chambers, and controlled production environments.

Pharmaceutical and biotechnology companies dominated the industry in 2023

By end user, the pharmaceutical and biotechnology companies segment accounted for the largest market share in 2023, owing to strict regulatory requirements and expanding biologics and vaccine production. Healthcare facilities also represent a significant segment due to rising hospital-acquired infection concerns.

North America to maintain its dominance by 2033

Region wise, North America held the largest market share in 2023 and is expected to maintain its dominance through 2033. This is attributed to advanced healthcare infrastructure, strong regulatory frameworks, and high investments in pharmaceutical research and cleanroom technologies. Europe and Asia-Pacific are also witnessing steady growth due to expanding manufacturing capabilities and increasing biosafety awareness.

Key Players

  • Fedegari Autoclavi SpA
  • Steris PLC
  • TOMI Environmental Solutions, Inc
  • Ecolab Inc
  • JCE Biotechnology
  • DIOP GmbH & Co. KG
  • Howorth Air Technology Ltd.
  • Zhejiang TAILIN Bioengineering Co., LTD.
  • AM Instruments SRL
  • Solidfog Technologies

Why Is Demand Increasing in the Bio Decontamination Market?

Demand for bio decontamination solutions is rising due to the increasing prevalence of hospital-acquired infections (HAIs), growing awareness of biosafety standards, and stricter regulatory requirements in healthcare and pharmaceutical sectors. Facilities are prioritizing contamination control to ensure patient safety, maintain sterile environments, and comply with Good Manufacturing Practices (GMP).

The expansion of pharmaceutical, biotechnology, and vaccine manufacturing is a major driver, as cleanrooms, isolators, and production suites require validated decontamination systems to prevent microbial contamination. Healthcare facilities are also investing in automated room and equipment sterilization technologies to reduce infection risks and enhance operational efficiency.

Technological advances further boost demand. Innovations such as hydrogen peroxide vapor systems, chlorine dioxide and nitrogen dioxide sterilization, IoT-enabled monitoring, and automated cycle validation improve process reliability, reduce human intervention, and minimize downtime. In addition, the growing focus on eco-friendly and sustainable sterilization solutions supports broader adoption globally, positioning the bio decontamination market for sustained growth.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A323971

Recent Development

  • In July 2022, Ecolab Inc announced that HPV-AQ 35% hydrogen peroxide disinfectant received an approval from the European Chemicals Agency (ECHA) Biocidal Products Committee (BPC) for a BPR EU (Union) authorization. Ecolab's Bioquell HPV-AQ is authorized for use in all territories of the European Union and the European Economic Area.
  • In January 2024, Steris plc introduced a new line of hydrogen peroxide-based bio decontamination systems with improved efficiency and faster cycle times, addressing rising demand for quicker and more effective sterilization solutions in healthcare and biotech settings.

The report provides a detailed analysis of these key players in the global bio decontamination market. These players have adopted different strategies such as expansion, product launch, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Healthcare Industry:

Inhaled Nitric Oxide Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Hospital Beds Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Animal Model Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Flow Cytometry Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Atopic Dermatitis Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Nerve Repair and Regeneration Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Companion Animal Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

Sleep Apnea Implants Market - Global Opportunity Analysis and Industry Forecast, 2024-2035

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. Each data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int'l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Logo - https://mma.prnewswire.com/media/636519/5815050/Allied_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bio-decontamination-market-to-reach-525-4-million-by-2033-globally-at-8-7-cagr-allied-market-research-302692872.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.